Plasma kynurenines and prognosis in patients with heart failure
Open Access
- 10 January 2020
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 15 (1) , e0227365
Abstract
Metabolites of the kynurenine pathway (mKP) relate to important aspects of heart failure pathophysiology, such as inflammation, energy-homeostasis, apoptosis, and oxidative stress. We aimed to investigate whether mKP predict mortality in patients with heart failure. The study included 202 patients with heart failure (73.8% with coronary artery disease (CAD)), propensity score matched to 384 controls without heart disease, and 807 controls with CAD (71%). All underwent coronary angiography and ventriculography at baseline. Plasma mKP, pyridoxal 5’phosphate (PLP) and CRP were measured at baseline. Case-control differences were assessed by logistic regression and survival by Cox regression, adjusted for age, gender, smoking, diabetes, ejection fraction, PLP, eGFR and CRP. Effect measures are reported per standard deviation increments. Higher plasma levels of kynurenine, 3- hydroxykynurenine (HK), quinolinic acid (QA), the kynurenine-tryptophan-ratio (KTR) and the ratio of HK to xanthurenic acid (HK/XA) were detected in heart failure compared to both control groups. The mortality rate per 1000 person-years was 55.5 in patients with heart failure, 14.6 in controls without heart disease and 22.2 in CAD controls. QA [HR 1.80, p = 0.013], HK [HR 1.77, p = 0.005], HK/XA [HR 1.67, p < 0.001] and KTR [HR 1.55, p = 0.009] were associated with increased mortality in patients with heart failure, while XA [HR 0.68–0.80, p = 0.013–0.037] were associated with lower mortality in all groups. HK and HK/XA had weak associations with increased mortality in CAD-controls. Elevated plasma levels of mKP and metabolite ratios are associated with increased mortality, independent of CAD, in patients with heart failure.Keywords
Funding Information
- Helse Vest Regionalt Helseføretak (912072)
This publication has 44 references indexed in Scilit:
- Acute tryptophan depletion in humans: a review of theoretical, practical and ethical aspectsJournal of Psychiatry and Neuroscience, 2013
- Oxidative Stress in Heart Failure: What Are We Missing?The American Journal of the Medical Sciences, 2011
- The kynurenine system and immunoregulationJournal of Neural Transmission, 2011
- Induction of indoleamine 2,3-dioxygenase by interferon-gamma in human lens epithelial cells: Apoptosis through the formation of 3-hydroxykynurenineThe International Journal of Biochemistry & Cell Biology, 2010
- Structure, expression, and function of kynurenine aminotransferases in human and rodent brainsCellular and Molecular Life Sciences, 2009
- The kynurenines are associated with oxidative stress, inflammation and the prevalence of cardiovascular disease in patients with end-stage renal diseaseAtherosclerosis, 2009
- Quantitative profiling of biomarkers related to B‐vitamin status, tryptophan metabolism and inflammation in human plasma by liquid chromatography/tandem mass spectrometryRapid Communications in Mass Spectrometry, 2009
- The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery diseaseJACC, 2004
- Analysis of Incomplete Multivariate Data (Monographs on Statistics and Applied Probability, No. 72)Journal of the American Statistical Association, 2000
- Neuronal Apoptosis Induced by Pharmacological Concentrations of 3‐HydroxykynurenineJournal of Neurochemistry, 2000